Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Amantadine for Weight Stabilization During Olanzapine Treatment
This study is currently recruiting participants.
Study NCT00287352 Information provided by The University of North Carolina, Chapel Hill
First Received: February 3, 2006 Last Updated: March 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psychotic Disorder
Schizophreniform Disorder
Schizophrenia
Schizoaffective Disorder
Additional conditions recognized in this trial
Disease
Mood Disorders
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Olanzapine, Amantadine
amantadine
Additional drug interventions recognized in this trial
Olanzapine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Dyskinesia Agents
Anti-Infective Agents
Antiemetics
Antiparkinson Agents
Antipsychotic Agents
Antiviral Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
The University of North Carolina, Chapel Hill
Eli Lilly and Company
Back to top of Main Content
